My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

178.94 +0.89 (+0.50%)

Official Closing Price Updated: 7:00 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest

November 16, 2025

Looking back on drug development inputs & services stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.

Via StockStory

5 Must-Read Analyst Questions From Charles River Laboratories’s Q3 Earnings Call

November 12, 2025

Charles River Laboratories’ third quarter results were met with negative market reaction, as investors focused on the company’s muted top-line growth and margin pressures. Management cited ongoing...

Via StockStory

Topics Earnings

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

3 Healthcare Stocks We Approach with Caution

November 09, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...

Via StockStory

Topics Stocks

Corporate Earnings Fuel Market Gains, But Mixed Results Hint at Underlying Volatility

November 07, 2025

Recent third-quarter (Q3) 2025 corporate earnings have painted a complex yet largely positive picture for North American equity markets. While robust performances from key sectors, particularly...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

This Charles River Laboratories Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

November 06, 2025

Via Benzinga

Robinhood To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday ↗

November 06, 2025

Via Benzinga

CRL Q3 Deep Dive: Portfolio Streamlining and End Market Stabilization Shape Outlook

November 06, 2025

Lab services company Charles River Laboratories (NYSE:CRL) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.00 billion. Its non-GAAP profit...

Via StockStory

Charles River (CRL) Q3 2025 Earnings Transcript ↗

November 05, 2025

Charles River (CRL) Q3 2025 Earnings Transcript

Via The Motley Fool

Charles River Beat Expectations But Why Is The Stock Falling? ↗

November 05, 2025

Charles River stock dips as Q3 revenue slips, EPS beats estimates, and company raises 2025 outlook with cost cuts and $1 billion buyback plan.

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

November 05, 2025

Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Why Charles River Laboratories (CRL) Shares Are Getting Obliterated Today

November 05, 2025

Shares of lab services company Charles River Laboratories (NYSE:CRL) fell 5.8% in the morning session after the company reported third-quarter results that revealed significant underlying weaknesses.

Via StockStory

Topics Artificial Intelligence

Wednesday's session: gap up and gap down stock in the S&P500 index ↗

November 05, 2025

Stay tuned for the market movements in the S&P500 index on Wednesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Charles River Laboratories (NYSE:CRL) Tops Q3 Earnings Estimates Despite Flat Revenue ↗

November 05, 2025

Charles River Labs Q3 earnings beat estimates with $2.43 EPS. The company raised its full-year EPS guidance while navigating a slight revenue decline.

Via Chartmill

Topics Earnings

Charles River Laboratories’s (NYSE:CRL) Q3: Beats On Revenue

November 05, 2025

Lab services company Charles River Laboratories (NYSE:CRL) announced better-than-expected revenue in Q3 CY2025, but sales were flat year on year at $1.00 billion. Its non-GAAP profit of $2.43 per share...

Via StockStory

What To Expect From Charles River Laboratories’s (CRL) Q3 Earnings

November 03, 2025

Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results this Wednesday before market hours. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

Discover which S&P500 stocks are making waves on Thursday. ↗

October 16, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.

Via Chartmill

3 Reasons to Avoid CRL and 1 Stock to Buy Instead

October 14, 2025

The past six months have been a windfall for Charles River Laboratories’s shareholders. The company’s stock price has jumped 60.1%, hitting $170.64 per share. This was partly due to its solid quarterly...

Via StockStory

Winners And Losers Of Q2: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Drug Development Inputs & Services Stocks

October 08, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Charles River Laboratories (NYSE:CRL) and its peers.

Via StockStory

Why Charles River Stock May Struggle In Its Final Phase ↗

October 07, 2025

Adhishthana.com notes Charles River Stock is nearing its Phase 18, with momentum weakening and long-term outperformance looking unlikely.

Via Benzinga

Charles River Laboratories (CRL) Stock Is Up, What You Need To Know

October 03, 2025

Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 2.6% in the afternoon session after the stock's positive momentum continued, as Barclays upgraded the company to Overweight...

Via StockStory

What's going on in today's session: S&P500 movers ↗

October 02, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Via Chartmill

Why Charles River Laboratories (CRL) Stock Is Up Today

October 02, 2025

Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 1.9% in the morning session after Barclays upgraded the company to Overweight from Equal-Weight and raised its price target.

Via StockStory

Topics Government

Wondering what's happening in today's S&P500 pre-market session? ↗

October 02, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

7 Analysts Assess Charles River: What You Need To Know ↗

October 02, 2025

Via Benzinga

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years ↗

October 01, 2025

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.

Via Benzinga

Topics Government

Wednesday's session: top gainers and losers in the S&P500 index ↗

October 01, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

Which S&P500 stocks are moving on Wednesday? ↗

October 01, 2025

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.